INGENIUM Emilia Romagna
VC Fund
Brussels, Belgium
INGENIUM Emilia Romagna is a VC fund in Brussels focused on Medical and Biotechnology. INGENIUM Emilia Romagna was started with EUR 5.30 million by the Emilia Romagna region and EUR 1.7 million from fund managers. Managed by META Investment, the nine-year fund operated through the temporary acquisition of minority stakes in high-opportunity technological companies. It is now fully invested.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries INGENIUM Emilia Romagna invests in
Stages INGENIUM Emilia Romagna invests in
Countries INGENIUM Emilia Romagna invests in
Round sizes
Round size
- Seed
- $276k–$2.8M
- Series A
- $1.1M–$2.2M
Investment Focus
Industry
- Medical 3 (33%)
- Biotechnology 3 (33%)
- Health Care 2 (22%)
- Manufacturing 2 (22%)
- Information Technology 2 (22%)
Stage
- Seed 4 (44%)
- Series A 2 (22%)
- Angel 1 (11%)
- Debt Financing 1 (11%)
- Venture - Series Unknown 1 (11%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Users can make and store passwords in a single, organized list, then access them from anywhere leaving no traces behind on the computer. Secure collaboration features allow users to make, send, share or provision passwords to colleagues, clients and partners -- a secure alternative to spreadsheets in the workplace. Managed via a central onlinerepository.Passpack is a free, professional tool. Optional premium upgrades are available for the micro-small business sector. | $950K / Debt Financing / Jun 30, 2018 | ||
| GreenBone develops a wood-derived bone implants technology to generate biomimetic – reabsorbable– load bearing implant suitable to address non-union fractures. The idea was conceived and developed by a research group of ISTEC-CNR of Faenza comprised of Andrea Ruffini, Simone Sprio and Anna Tampieri. | $3.4M / Venture - Series Unknown / Sep 23, 2015 | ||
| Fazland is an innovative web and mobile platform developed by the Italian startup Midnight Call Srl. The platform enables private clients to compare offers for home services and it helps efficient tradesmen to get in touch with potential customers in an easy and smart way. Midnight Call Srl was founded in October 2011 in Reggio Emilia (Italy).Following an initial phase of R&D, the product has become commercially available in March 2013.Following a very encouraging first year of operations, the company recieved a seed investment from the Italian venture capital fund RedSeed Ventures and some Angel Investors in July 2014. Through continuous product improvements and a solid commercial approach, the company has managed to build a solid position in the Italian market and launch pilot tests in few European cities. | $1.1M / Series A / Sep 14, 2015 | ||
| GustaMente produces gluten-free dietetic food. The company offers a line of traditional Italian food such as fresh egg pasta and complementary products such as sauces, thereby providing products that are gluten-free, without palm oil, preservatives or lactose, organic and easy to cook. | $662.9K / Seed / Jul 01, 2015 | ||
| Condomani é il social network gestionale ideato per rivoluzionare il modo di vivere il condominio. Con Condomani finalmente potrai avere il condominio nelle tue mani e gestire dovunque avvisi, contabilità, assemblee condominiali, monitorare i lavori in corso, etc. Sei pronto a rivoluzionare insieme a noi il tuo condominio? Iscriviti gratisCondomanié il social network per il rivoluzionare gestionale ideato di vivere il mode condo. With Condomani finally potrai avere il nelle tue condo peanuts and dovunque gestire avvisi, contabilità, assemblee condominiali, monitorare i lavori in corso, etc.. Sei soon rivoluzionare insieme a noi il tuo condo? free iscriviti | $275.9K / Seed / Apr 01, 2014 | ||
| Cellply is a life-science company focused on developing next-generation analytical tools enabling a deep characterization of cancer immunotherapies, cell therapies and cell-based biotherapeutics. The company aims to support the development of novel cancer immunotherapies by accelerating R&D, automating the quality control and advancing theability to monitor the clinical response to these treatments.Through the use of proprietary microfluidic technologies with Co-Culture Array technology, highly-automated analytical instruments and AI-powered image and data analytics, Cellply products define the function of the immune system one cell at a time, combining functional data with other multiplex data and providing unprecedented single-cell analytical solutions. | $2.8M / Seed / Mar 20, 2014 | ||
| Angiodroid srl, a medical technology company, focuses on hemodynamics, vascular surgery, and interventional radiology. It offers an automatic injection system for carbon dioxide angiography. Its products include carbon dioxide injector that is used as a contrast medium for pheriperal interventional angiography; and a single use kit, which iscomposed of French catheters and a custom connection line. The company is based in San Lazzaro di Savena, Italy. | $2.1M / Seed / Oct 22, 2013 | ||
| Users can make and store passwords in a single, organized list, then access them from anywhere leaving no traces behind on the computer. Secure collaboration features allow users to make, send, share or provision passwords to colleagues, clients and partners -- a secure alternative to spreadsheets in the workplace. Managed via a central onlinerepository.Passpack is a free, professional tool. Optional premium upgrades are available for the micro-small business sector. | $465K / Angel / May 16, 2008 | ||
| Intrauma was founded in 2006 and is based in Rivoli, near Turin, in Piedmont. The company designs and manufactures the O’nil range of locking plates, which has been in clinical use since 1998. Intrauma is committed to on-going research and development of both materials and manufacturing processes, in collaboration with experienced trauma surgeons,to provide the highest quality implants and to simplify today’s approach to Traumatology. Intrauma is also dedicated to building and maintaining strong customer relationships, believing that this is the foundation of a successful business.Intrauma TODAYToday, Intrauma is the second largest supplier of trauma devices in Italy, and is rapidly expanding its international sales and marketing operations across the world.This also gives the company the opportunity to work with surgeons across the globe, developing more unique products and continuing to improve traumatology techniques for the benefit of both patient and surgeon. | $2.2M / Series A / Jan 01, 2008 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does INGENIUM Emilia Romagna invest in?
INGENIUM Emilia Romagna invests primarily in Medical, Biotechnology and Health Care startups, most often at Seed and Series A stage. Most of the 9 investments tracked by Shizune back companies in Italy. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does INGENIUM Emilia Romagna invest in?
INGENIUM Emilia Romagna typically joins rounds of $276k–$2.8M at Seed and $1.1M–$2.2M at Series A. These are whole funding-round sizes, not INGENIUM Emilia Romagna's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds INGENIUM Emilia Romagna took part in.
When did INGENIUM Emilia Romagna last invest?
The most recent investment recorded for INGENIUM Emilia Romagna closed in Jun 2018. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
